Trends in Leading Cancer Incidence among Iranian Women: Annual Cancer Registry Reports, 2003-2015
Abstract
Background: Cancer is one of the most important causes of death in the world and has an increasing trend globally. We aimed at investigating the five leading cancers in Iranian women based on a 10-year history of cancer registry reports and illustrating the trends in all cancer sites and breast cancer as the top leading one from 2003 to 2015.
Methods: Data were obtained from national cancer registry study. Age-Specific Incidence Rate (ASR) data were obtained from Iran’s annual national cancer registry reports between 2003 to 2010 and 2014 to 2015. Using Joinpoint regression, we analyzed incidence trends over time for all cancer sites and the top leading cancer from 2003 to 2015.
Results: Breast cancer was ranked first in Iranian women. Its ASR raised from 15.96 in 2003 to 32.63 in 2015. Results of trend analysis based on Annual Percent Change (APC) index showed 5.6 (95%CI: 2.9 to 8.3) and 4.6 (95%CI: 2.0 to 7.2) annual increase in the incidence of all cancer sites and breast cancer from 2003 to 2015, respectively.
Conclusion: This study indicates significant increasing trends in all cancer sites and breast cancer incidence in Iran. Despite the national coverage of cancer registry over the past decade, more considerations should be taken into account, especially in Breast cancer.
1. Ferlay J, Colombet M, Soerjomataram I, et al (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer, 144(8):1941-153.
2. Cancer (2019) Who.int. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
3. Smetana K, Lacina L, Szabo P, et al (2016). Ageing as an important risk factor for cancer. Anticancer Res, 36(10):5009-5017.
4. Franceschi S, Wild CP (2013). Meeting the global demands of epidemiologic transition–The indispensable role of cancer prevention. Mol Oncol, 7(1): 1–13.
5. Panahi MH, Panahi H, Mahdavi Hezaveh A, et al (2019). Survival rate of colon and rectum cancer in Iran: a systematic review and meta-analysis. Neoplasma, 66(6):988-994.
6. Worldwide cancer incidence statistics (2019). Cancer Research UK. Available from: https://www.cancerresearchuk.org/health
7. Naghavi M, Shahraz S, Sepanlou SG, et al (2014). Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med, 17(5):321-35.
8. Sasanipour M, Asadi S (2017). Epidemiologic transition in Iran with emphasis on the third stage of transition. J Community Health Res, 6(4):248-57.
9. Mirzaei H, Panahi M, Etemad K, et al (2016). Evaluation of Pilot Colorectal Cancer Screening Programs in Iran. Iranian Journal of Epidemiology, 12(3):21-28.
10. Basic Information About Breast Cancer: CDC. Available from: https://www.cdc.gov/cancer/breast/basic_info
11. Bouchardy C, Rapiti E and Benhamou S (2014). Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths. Ecancermedicalscience, 8.
12. Parkin DM (2008). The role of cancer registries in cancer control. Int J Clin Oncol, 13(2):102-11.
13. Bray F, Znaor A, Cueva P, et al ( 2014). Planning and Developing Population-Based Cancer Registration in Low- or Middle-Income Settings. International Agency for Research on Cancer, Lyon (FR).
14. Iranian Annual Cancer Registration Report [In Persian] (2003-2010). Ministry of Health and Medical Education, Health Deputy Center for Disease Control and Prevention.
15. Iranian Annual Cancer Registration Report [In Persian]( 2014-2015). Ministry of Health and Medical Education, Health Deputy Center for Disease Control and Prevention.
16. Jack A, Percy C, Sobin L, et al (2000). International classification of diseases for oncology: ICD-O. World Health Organization.
17. dos Santos Silva I (1999). Cancer epidemiology: principles and methods. IARC.
18. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000). Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 19(3):335-51.
19. Breast cancer: WHO. Available from: https://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
20. Brenner DR, Ruan Y, Shaw E, et al (2019). Age-standardized cancer-incidence trends in Canada, 1971–2015. CMAJ, 191(46):E1262-E73.
21. Cronin KA, Lake AJ, Scott S, et al (2018). Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer, 126(10):2225-2249.
22. Akdeniz D, Klaver MM, Smith CZ, et al (2020). The impact of lifestyle and reproductive factors on the risk of a second new primary cancer in the contralateral breast: a systematic review and meta-analysis. Cancer Causes Control, 31(5): 403-416.
23. Gierisch JM, Coeytaux RR, Urrutia RP, et al (2013). Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol. Biomark. Prev, 22(11):1931-43.
24. Wiseman RA (2004). Breast cancer: critical data analysis concludes that estrogens are not the cause, however lifestyle changes can alter risk rapidly. J Clin Epidemiol, 57(8):766-72.
25. Protani M, Coory M, Martin JH (2010). Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 123(3):627-35.
26. Moorman PG, Havrilesky LJ, Gierisch JM, et al (2013). Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol, 31(33):4188-98.
27. Botha J, Bray F, Sankila R, Parkin DM (2003). Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer, 39(12):1718-29.
28. Howlader N, Noone AM, Krapcho M, et al (2014). SEER cancer statistics review, 1975–2011. Bethesda, MD: National Cancer Institute. Available from: https://seer.cancer.gov/archive/csr/1975_2011/
29. Howlader NN, Noone AM, Krapcho M, et al (2016). SEER cancer statistics review, 1975–2013. Bethesda, MD: National Cancer Institute. Available from: https://seer.cancer.gov/archive/csr/1975_2013/
30. Movahedi M, Haghighat S, Khayamzadeh M, et al (2012). Survival rate of breast cancer based on geographical variation in iran, a national study. Iran Red Crescent Med J, 14(12):798-804.
31. Harirchi I, Karbakhsh M, Kashefi A, et al (2004). Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev, 5(1):24-7.
32. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast Cancer in Iran: An Epidemiological Review. Breast J, 13(4):383-91.
33. Fares MY, Salhab HA, Khachfe HH, et al (2019). Breast cancer epidemiology among Lebanese women: an 11-year analysis. Medicina (Kaunas), 55(8):463.
34. Mousavi SM, Zheng T, Dastgiri S, et al (2009). Age Distribution of Breast Cancer in the Middle East, Implications for Screening. Breast J, 15(6):677-9.
2. Cancer (2019) Who.int. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
3. Smetana K, Lacina L, Szabo P, et al (2016). Ageing as an important risk factor for cancer. Anticancer Res, 36(10):5009-5017.
4. Franceschi S, Wild CP (2013). Meeting the global demands of epidemiologic transition–The indispensable role of cancer prevention. Mol Oncol, 7(1): 1–13.
5. Panahi MH, Panahi H, Mahdavi Hezaveh A, et al (2019). Survival rate of colon and rectum cancer in Iran: a systematic review and meta-analysis. Neoplasma, 66(6):988-994.
6. Worldwide cancer incidence statistics (2019). Cancer Research UK. Available from: https://www.cancerresearchuk.org/health
7. Naghavi M, Shahraz S, Sepanlou SG, et al (2014). Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med, 17(5):321-35.
8. Sasanipour M, Asadi S (2017). Epidemiologic transition in Iran with emphasis on the third stage of transition. J Community Health Res, 6(4):248-57.
9. Mirzaei H, Panahi M, Etemad K, et al (2016). Evaluation of Pilot Colorectal Cancer Screening Programs in Iran. Iranian Journal of Epidemiology, 12(3):21-28.
10. Basic Information About Breast Cancer: CDC. Available from: https://www.cdc.gov/cancer/breast/basic_info
11. Bouchardy C, Rapiti E and Benhamou S (2014). Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths. Ecancermedicalscience, 8.
12. Parkin DM (2008). The role of cancer registries in cancer control. Int J Clin Oncol, 13(2):102-11.
13. Bray F, Znaor A, Cueva P, et al ( 2014). Planning and Developing Population-Based Cancer Registration in Low- or Middle-Income Settings. International Agency for Research on Cancer, Lyon (FR).
14. Iranian Annual Cancer Registration Report [In Persian] (2003-2010). Ministry of Health and Medical Education, Health Deputy Center for Disease Control and Prevention.
15. Iranian Annual Cancer Registration Report [In Persian]( 2014-2015). Ministry of Health and Medical Education, Health Deputy Center for Disease Control and Prevention.
16. Jack A, Percy C, Sobin L, et al (2000). International classification of diseases for oncology: ICD-O. World Health Organization.
17. dos Santos Silva I (1999). Cancer epidemiology: principles and methods. IARC.
18. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000). Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 19(3):335-51.
19. Breast cancer: WHO. Available from: https://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
20. Brenner DR, Ruan Y, Shaw E, et al (2019). Age-standardized cancer-incidence trends in Canada, 1971–2015. CMAJ, 191(46):E1262-E73.
21. Cronin KA, Lake AJ, Scott S, et al (2018). Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer, 126(10):2225-2249.
22. Akdeniz D, Klaver MM, Smith CZ, et al (2020). The impact of lifestyle and reproductive factors on the risk of a second new primary cancer in the contralateral breast: a systematic review and meta-analysis. Cancer Causes Control, 31(5): 403-416.
23. Gierisch JM, Coeytaux RR, Urrutia RP, et al (2013). Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol. Biomark. Prev, 22(11):1931-43.
24. Wiseman RA (2004). Breast cancer: critical data analysis concludes that estrogens are not the cause, however lifestyle changes can alter risk rapidly. J Clin Epidemiol, 57(8):766-72.
25. Protani M, Coory M, Martin JH (2010). Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 123(3):627-35.
26. Moorman PG, Havrilesky LJ, Gierisch JM, et al (2013). Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol, 31(33):4188-98.
27. Botha J, Bray F, Sankila R, Parkin DM (2003). Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer, 39(12):1718-29.
28. Howlader N, Noone AM, Krapcho M, et al (2014). SEER cancer statistics review, 1975–2011. Bethesda, MD: National Cancer Institute. Available from: https://seer.cancer.gov/archive/csr/1975_2011/
29. Howlader NN, Noone AM, Krapcho M, et al (2016). SEER cancer statistics review, 1975–2013. Bethesda, MD: National Cancer Institute. Available from: https://seer.cancer.gov/archive/csr/1975_2013/
30. Movahedi M, Haghighat S, Khayamzadeh M, et al (2012). Survival rate of breast cancer based on geographical variation in iran, a national study. Iran Red Crescent Med J, 14(12):798-804.
31. Harirchi I, Karbakhsh M, Kashefi A, et al (2004). Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev, 5(1):24-7.
32. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast Cancer in Iran: An Epidemiological Review. Breast J, 13(4):383-91.
33. Fares MY, Salhab HA, Khachfe HH, et al (2019). Breast cancer epidemiology among Lebanese women: an 11-year analysis. Medicina (Kaunas), 55(8):463.
34. Mousavi SM, Zheng T, Dastgiri S, et al (2009). Age Distribution of Breast Cancer in the Middle East, Implications for Screening. Breast J, 15(6):677-9.
| Files | ||
| Issue | Vol 50 No 8 (2021) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v50i8.6818 | |
| Keywords | ||
| Cancer trend Annual percent change Cancer registry Cancer statistics Breast cancer | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Bidhendi Yarandi R, Panahi MH. Trends in Leading Cancer Incidence among Iranian Women: Annual Cancer Registry Reports, 2003-2015. Iran J Public Health. 2021;50(8):1705-1712.
